Medical Discoveries | Pharma Voice | Experimental | Safety Innovations | Certifications & Approvals | Laboratories
Dr. Reddy’s to acquire select Anti-Allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan
US-FDA Approved Foundation Medicine’s FoundationOne®Liquid CDx, a Pan-Tumor Liquid Biopsy Genomic Test for Late Stage Cancer Patients now Available in India
The Himalaya Drug Company Introduces Q-DEE Range of Mouth Dissolving Tablets for Immunity and Cramps
Herbostra: Modernizing Conventional Ayurvedic Products
Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg
Jubilant Pharma Ltd. and Aavis Pharmaceuticals launch Hydroxychloroquine Sulfate tablets in the U.S. market
#InhalersHainSahi – #BerokZindagi is back with its third chapter to create awareness about asthma and inhalation therapy
BDR Pharma launches generic version of Lenvatinib for cancer patients in India
BDR Pharma launches Nintenib (Nintedanib) to treat Idiopathic Pulmonary Fibrosis in India
PharmaLytica Virtual Expo Connect: India’s Largest Pharmaceutical Virtual Marketplace for APIs, Pharma Packaging, Machinery, Lab, & Analytical Services
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has
Hypertrophic cardiomyopathy (HCM) affects the health of the heart muscle. Genetic cause of 40-50% of HCM are not known. The mutations responsible for HCM often
India’s leading Sports Nutrition Brand Animal Booster Nutrition has become one of the most trusted brands of the country within a short span of time
India’s leading Sports Nutrition Brand Animal Booster Nutrition has become one of the most trusted brands of the country within a short span of time
The European Commission as approved use of Vertex’ Symkevi (tezacaftor/ivacaftor) with Kalydeco (ivacaftor) for eligible children with cystic fibrosis (CF) aged 6-11 years. The combination
European regulators will review Merck’s tepotinib for a specific type of lung cancer, having validated the drug’s marketing application. Tepotinib is designed to treat advanced
Novartis’ Adakveo (crizanlizumab) has hit a setback having failed to gain acceptance by the National Institute for Health and Care Excellence (NICE). The cost watchdog
The NHS is trialling an innovative new blood test that may be able to detect more than 50 types of cancer. The Galleri blood test,
Topgallant Media organized the COVID Warriors Award 2020. Which was a ceremony to acknowledge and felicitate the leading contributors who have taken the initiative to
Patients with a difficult to treat form of multiple myeloma will now gain access to a new treatment on the NHS in England and Wales,
